Antara Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Antara Capital’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000,000	Closed	-$2.38M	–	221
2022 Q3	$2.38M	Sell	2,000,000 -200,000	-9%	-$312K	0.06%	103
2022 Q2	$3.96M	Buy	+2,200,000	New	+$3.25M	0.17%	103
2021 Q3	–	Sell	-625,000	Closed	-$3.63M	–	239
2021 Q2	$3.63M	Buy	+625,000	New	+$3.66M	0.2%	76
2020 Q4	–	Sell	-1,150,000	Closed	-$6.71M	–	73
2020 Q3	$6.71M	Buy	+1,150,000	New	+$6.88M	0.93%	25
2020 Q2	–	Sell	-2,164,100	Closed	-$13.8M	–	72
2020 Q1	$13.8M	Buy	2,164,100 +1,564,100	+261%	+$12.5M	2.23%	15
2019 Q4	$6.25M	Buy	600,000 +75,000	+14%	+$545K	1.27%	24
2019 Q3	$2.06M	Buy	525,000 +150,000	+40%	+$1.21M	0.96%	18
2019 Q2	$5.58M	Buy	375,000 +275,000	+275%	+$4.97M	1.21%	25
2019 Q1	$2.48M	Buy	100,000 +30,000	+43%	+$752K	0.7%	35
2018 Q4	$1.26M	Buy	+70,000	New	+$1.43M	0.86%	24

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Antara Capital's CLVS Position: Q3 2019 in Review

Antara Capital sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 50,000 shares — an estimated $404K sold.

Antara Capital first reported a position in CLVS in Q4 2018 and held it in 3 quarters. The position peaked at $2.15M in Q4 2018. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

Antara Capital reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
Antara Capital sold 50,000 Clovis Oncology, Inc. shares in Q3 2019, an estimated $404K.
Antara Capital first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 3 quarters.
Antara Capital's Clovis Oncology, Inc. position peaked at $2.15M in Q4 2018.
153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Antara Capital's 13F filing for Q3 2019, filed 14 Nov 2019.